International CDKL5 Clinical Research Network

Plain-language summary

This is an observational study that follows individuals with CDKL5 deficiency disorder through a research network and registry; no drug or treatment is given. People aged 1 month to 100 years who receive care at participating centers or are registered in the international CDKL5 database can take part. It is a non-interventional (observational) study and is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

University of Colorado, Denver

Intervention

No intervention.

Start date

2/15/2021

Estimated completion

2/15/2027

Countries

United States, Australia

Related genes

Locations

• Los Angeles, United States
• Aurora, United States
• Boston, United States
• St Louis, United States
• New York, United States
• Cleveland, United States
• Philadelphia, United States
• Houston, United States
• Perth, Australia

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* All children diagnosed with CDD age 1-month to 100 years of age that are receiving care at one of the study institutions or are registered with the International CDKL5 Disorder Database will be considered for the study population.

Exclusion Criteria:

* Individuals who do not meet study inclusion criteria.